New data from the phase 3 TYREE study demonstrate efficacy of a fixed-dose combination of budesonide and albuterol in a single pressurized metered-dose inhaler to prevent exercise-induced bronchoconstriction in individuals with asthma.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.